Replies to post #781 on GTC Biotherapeutics (fka GTCB)

[mblimon]

I know it concerns plasma ATiii. I was not referring to Atryn. My question is whether a clinical center is allowed to do such experiments without an officially accepted protocol (by the EMEA) or whether existing approvals for plasma ATiii indications allow these experiments, because they are very similar to what has been done.